S
Samir Abu-Rumeileh
Researcher at University of Bologna
Publications - 38
Citations - 1328
Samir Abu-Rumeileh is an academic researcher from University of Bologna. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 27 publications receiving 708 citations. Previous affiliations of Samir Abu-Rumeileh include University of Ulm & Martin Luther University of Halle-Wittenberg.
Papers
More filters
Journal ArticleDOI
Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
TL;DR: COVID-19-associated GBS seems to share most features of classic post-infectious GBS and possibly the same immune-mediated pathogenetic mechanisms, Nevertheless, more extensive epidemiological studies are needed to clarify these issues.
Journal ArticleDOI
Guillain-Barré syndrome following COVID-19: new infection, old complication?
Marina Padroni,Vincenzo Mastrangelo,Gian Maria Asioli,Lucia Pavolucci,Samir Abu-Rumeileh,Maria Grazia Piscaglia,Pietro Querzani,Claudio Callegarini,Matteo Foschi +8 more
TL;DR: A 70-year-old-woman was referred to the emergency department (ED) on Mar-28 complaining of asthenia, hands and feet paresthesia and gait difficulties progressing within 1 day, and neurophysiologic findings were consistent with a diagnosis of GBS following a clinically resolved paucisymptomatic COVID-19.
Journal ArticleDOI
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Francesca Lattanzio,Samir Abu-Rumeileh,Alessia Franceschini,Hideaki Kai,Hideaki Kai,Giulia Amore,Ilaria Poggiolini,Marcello Rossi,Simone Baiardi,Lynne McGuire,Anna Ladogana,Maurizio Pocchiari,Alison Green,Sabina Capellari,Piero Parchi +14 more
TL;DR: Support is support for the use of both RT-QuIC and t-tau assays as first line laboratory investigations for the clinical diagnosis of CJD and a secondary tauopathy in CJD subtypes VV2 and MV2K, correlating with increased p-t Tau levels in the CSF is demonstrated.
Journal ArticleDOI
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Ahmed Abdelhak,Matteo Foschi,Samir Abu-Rumeileh,John K. Yue,Lucio D'Anna,André Huss,Patrick Oeckl,Albert C. Ludolph,Jens Kuhle,Axel Petzold,Geoffrey T. Manley,Ari J. Green,Markus Otto,Hayrettin Tumani +13 more
TL;DR: A systematic overview of the evidence regarding the utility of blood GFAP as a biomarker in neurological diseases is provided in this article , where the authors propose a model for GFAP concentration dynamics in different conditions and discuss the limitations that hamper the widespread use of GFAP in the clinical setting.
Journal ArticleDOI
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia.
Samir Abu-Rumeileh,Petra Steinacker,Barbara Polischi,Angela Mammana,Anna Bartoletti-Stella,Patrick Oeckl,Simone Baiardi,Corrado Zenesini,André Huss,Pietro Cortelli,Sabina Capellari,Markus Otto,Piero Parchi +12 more
TL;DR: CSF glial markers of neuroinflammation demonstrate limited diagnostic value but have some potential for monitoring the clinical and, possibly, preclinical phases of NDs.